AbbVie | ABBV - SCHULD

Aktienkurs
206.67
Täglich Wechseln
-2.17 -1.04%
Monatlich
-9.14%
Jährlich
10.79%
Q2 Prognose
202.55




SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Abbott USD 12.94B 496M 2025-09
ALKERMES USD 71.6M 1.08M 2025-09
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Infinity Pharmaceuticals USD 0 0 2022-06
J&J USD 45.8B 4.97B 2025-09
Medtronic USD 28.07B 1.03B 2025-12
Merck USD 41.37B 5.97B 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
UCB EUR 3.03B 12M 2024-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Zoetis USD 7.27B 482M 2025-09